• CORE Lipid Nanoparticles for Splenic mRNA Delivery

  2026-08-23

  The CORE study introduces cholesterol-altered lipid nanoparticles designed to redirect systemic mRNA expression from the liver toward the spleen. By combining cholesterol-analog synthesis, computational characterization, design-of-experiments optimization, and in vivo testing, the authors establish a material-driven strategy for extrahepatic delivery with potential relevance to vaccination and immune modulation.

• RNA Clean and Concentrator Kit for IVT RNA

  2026-08-22

  Turn transcription mixtures into assay-ready RNA with a streamlined RNA purification spin column workflow. The kit supports low-input cleanup, larger-scale in vitro transcription RNA cleanup, IRES reporter preparation, and practical troubleshooting without gel extraction or precipitation steps.

• GKT137831: Redox Control at the Membrane

  2026-08-21

  GKT137831 is a dual NADPH oxidase Nox1/Nox4 inhibitor for dissecting source-specific oxidative stress. This article connects vascular redox assays with new evidence on ferroptotic membrane failure, offering a practical framework without overstating the evidence.

• Budesonide for Airway Inflammation Research

  2026-08-21

  Budesonide supports a practical bridge between membrane-partition studies and cell-based asthma inflammation models. This guide combines IAM LC, LEKC, solvent-controlled dosing, and troubleshooting strategies to improve respiratory disease research reproducibility.

• Losartan Hydrogel Remodels Tumor Mechanics

  2026-08-20

  Hou et al. developed LOS&FeOX@Gel, an in situ nanocomposite hydrogel that uses sustained Losartan delivery to remodel the stiff, matrix-rich tumor microenvironment after chemotherapy. In preclinical models, this mechanical intervention improved oxaliplatin activity, strengthened antitumor immune effects, and sensitized post-chemotherapy tumors to checkpoint blockade, providing a rationale for mechanical-immunoengineering strategies.

• Tranexamic Acid: From Binding Sites to Clot Models

  2026-08-20

  Tranexamic Acid is an antifibrinolytic agent whose lysine-site mechanism enables precise studies of clot stabilization, fibrin breakdown, and cell-surface interactions. This article translates a 2024 wound-dressing study into practical decisions for designing interpretable fibrinolysis research assays.

• Piezo1, Matrix Stiffness, and DRG Axon Regeneration

  2026-08-19

  The 2024 Advanced Science study identifies substrate stiffness as a major regulator of dorsal root ganglion axon regrowth and connects mechanical sensing to a Piezo1–Ca2+–CaMKII–FAK–actin pathway. Its combination of tunable in vitro substrates, mechanistic signaling analysis, and sciatic nerve injury experiments suggests that Piezo1 can have context-dependent effects on peripheral nerve repair.

• Trifluoperazine 2HCl: Assay Workflows

  2026-08-19

  Trifluoperazine 2HCl combines nanomolar dopamine D2 receptor inhibition with practical solubility for controlled cell-based studies. This guide translates its use from neuropharmacology assays into macrophage ROS–autophagy workflows while emphasizing fresh stocks, orthogonal controls, and interpretation limits.

• 2',7'-Dichlorofluorescein diacetate in Translation

  2026-08-18

  A thought-leadership guide to using 2',7'-Dichlorofluorescein diacetate for intracellular ROS measurement, with a translational framework for interpreting redox biology in self-adaptive pancreatic cancer nanocarriers.

• D-Luciferin for Immunotherapy Assay Design

  2026-08-17

  D-Luciferin is a firefly luciferase substrate that can turn complex immunotherapy responses into longitudinal, quantitative signals. This article explains how to use bioluminescence imaging alongside the tumor-targeted αCD3&LIGHT strategy while avoiding common interpretation errors.

• Dabigatran etexilate: Practical Assay Workflows

  2026-08-17

  Build reproducible thrombin, plasma-clotting, and platelet-aggregation assays with Dabigatran etexilate, an oral prodrug that connects biochemical target engagement with translational anticoagulation research. This guide emphasizes stock preparation, assay selection, prodrug-conversion controls, and troubleshooting for atrial fibrillation and coagulation studies.

• Cefotaxime as a Lens on AMR Transmission

  2026-08-16

  Cefotaxime can serve as more than an antibacterial test compound: it is a mechanistic probe for linking cell-wall inhibition, beta-lactamase activity, plasmid mobility, and bacterial infection models. This thought-leadership guide translates recent CREC transmission findings into practical design principles for antimicrobial resistance research.

• Methylprednisolone Sodium Succinate: Research Workflows

  2026-08-15

  Build reproducible inflammation, neutrophil, cytokine, and apoptosis assays with a soluble synthetic corticosteroid and concentration-aware controls. This guide distinguishes direct product evidence from practical screening recommendations, while translating a phase-specific lesson from antiemetic research into better experimental design.

• QPRT, P2Y11, and Breast Cancer Invasion

  2026-08-15

  Liu and colleagues connect elevated quinolinate phosphoribosyltransferase (QPRT) with breast cancer invasiveness and identify myosin light chain phosphorylation as a downstream functional correlate. Their genetic and pharmacological experiments implicate purinergic signaling, including P2Y11, while also showing why receptor antagonism should be interpreted as pathway evidence rather than definitive receptor-specific proof.

• Digoxin B7684: Reliable Cell Assay Workflows

  2026-08-14

  A scenario-driven guide to using Digoxin (SKU B7684) as a Na+/K+ ATPase pump inhibitor in cell viability, proliferation, cytotoxicity, and chikungunya research. It covers formulation, controls, dose interpretation, storage, and practical product-selection criteria for more defensible laboratory results.

451 records 7/31 page Previous Next First page 上5页 678910 下5页 Last page